Vaccinations in studies of AstraZeneca and the University of Oxford's experimental coronavirus shot are on hold after an unexplained illness in one participant triggered a safety review, the British drugmaker confirmed to BioPharma Dive. The trial pause was first reported by STAT.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,